Guidance document : conduct and analysis of comparative bioavailability studies.: H164-346/2023E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.919266&sl=0
Department/Agency | Canada. Health Canada, issuing body. |
---|---|
Title | Guidance document : conduct and analysis of comparative bioavailability studies. |
Publication type | Monograph |
Language | [English] |
Other language editions | [French] |
Earlier edition | Guidance document |
Format | Electronic |
Electronic document | |
Note(s) | Issued also in French under title: Ligne directrice : conduite et analyse des études de biodisponibilité comparatives. "Date Adopted: 2012/02/08. Revised Date: 2023/01/30. Effective Date: 2018/09/01 (for submissions filed on or September 1, 2018)." |
Publishing information | Ottawa, ON : Health Canada = Santé Canada, 2023. ©2023 |
Description | 1 online resource (35 pages) |
ISBN | 9780660471624 |
Catalogue number |
|
Departmental catalogue number | 220708 |
Subject terms | Drugs -- Testing -- Government policy -- Canada. Drugs -- Bioavailability -- Canada. |